Cell Proliferation Kit Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Cell Proliferation Kit Market Analysis
The Cell Proliferation Kit (CPK) Market is expected to register a CAGR of 7.5% during the forecast period. The major factors attributing to the growth of the market are rising volume of patients diagnosed with cancer, tumors and ongoing R&D activities across the globe. As per World health Organization report, cancer is a leading cause of death worldwide and estimated that nearly 9.6 million deaths in 2018. Also, lung cancer was identified as the most common cancer leading to death with 1.76 million deaths in 2018. Thus, growing prevalence of these diseases resulted in earlier assessment of viable cell-count, metabolic activity for effective treatment fuels the market growth. Furthermore, rise in government initiatives to control the healthcare burden, and growing healthcare awareness among are likely boost the Cell Proliferation Kit market.
Cell Proliferation Kit Market Trends
This section covers the major market trends shaping the Cell Proliferation Kit Market according to our research experts:
Colorimetry Sub-segment is Expected to Hold a Major Market Share in the Cell Proliferation Kit Market
Colorimetry holds a significant market share in Cell Proliferation Kit market over the forecast period. The dominance is owing to increased adoption as measuring markers of cell activity. Huge demand for the method is due to their cost effectiveness, easier retrieval of high-throughput data, and key role in assessment of therapeutic efficacy. This method is widely employed determining various cellular activity such as DNA synthesis, metabolic activity, ATP production, the number of cells present etc., Various types of colorimetric assays like WST-1, WST-8, XTT, MTT, and others are available specific to tests. Thus, above mentioned factors are expected to fuel the growth of the segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the cell proliferation kit market. The dominance is due to growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Also, the presence of huge population of baby boomers leads to huge volume of elderly people who are at the risk of cancers. According to the estimates published by the American Cancer Society for the year 2020, lung cancer is the second most common cancer leading to 135,720 deaths in both men and women. Also, as per Thyroid Cancer Survivors Association, thyroid cancer affects nearly 52,890 new cases in the United States in 2020, which increased from 52,070 cases in the year 2019. Thus, growing cancer cases leads to increased demand for determining the growth rate of cellular population driving the growth of the market. Furthermore, ongoing research activities in oncology by key pharma and biotech companies necessitates the use of these kits to determine the therapeutic efficiency of drugs. Therefore, due to above mentioned factors expected to boost the cell proliferation kit market in the region to a large extent during the forecast period.
Cell Proliferation Kit Industry Overview
The cell proliferation kit market is moderately competitive and consists of a several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company, and Agilent Technologies Inc (BioTek Instruments Inc).
Cell Proliferation Kit Market Leaders
-
Merck KGaA
-
Thermo Fisher Scientific Inc
-
Bio-Rad Laboratories Inc
-
Becton, Dickinson and Company
-
Agilent Technologies Inc (BioTek Instruments Inc)
*Disclaimer: Major Players sorted in no particular order
Cell Proliferation Kit Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rise in Technological Advancements in Cell-based Methodologies
- 4.2.2 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
- 4.2.3 Increasing Application in Drug Screening
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Personnel to Operate these Technologies
- 4.3.2 High Maintenance and Operational Costs
- 4.3.3 Lesser Sensitive Results with Smaller Samples of Cells
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Assay Type
- 5.1.1 DNA Synthesis Cell Proliferation Assay
- 5.1.2 Metabolic Activity Cell Proliferation Assay
- 5.1.3 Antigen Associated Cell Proliferation Assay
-
5.2 Method
- 5.2.1 Colorimetry
- 5.2.2 Fluorescence
- 5.2.3 Others
-
5.3 End-user
- 5.3.1 Pharma & Biotech Companies
- 5.3.2 Academic & Research Institutes
- 5.3.3 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Thermo Fisher Scientific Inc
- 6.1.2 Merck KGaA
- 6.1.3 Bio-Rad Laboratories Inc
- 6.1.4 Becton, Dickinson and Company
- 6.1.5 Agilent Technologies Inc (BioTek Instruments Inc)
- 6.1.6 GE Healthcare
- 6.1.7 Perkin Elmer Inc
- 6.1.8 Biological Industry
- 6.1.9 Biotium
- 6.1.10 Mindray Medical International Limited
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCell Proliferation Kit Industry Segmentation
Cell proliferation is a process of cell replication, which plays a key role from the time of embryogenesis to maintenance of adult tissue homoeostasis by recycling the old cells with new cells. In a few disease conditions like cancer, abnormal cell proliferation is observed. Thus, cell proliferation assay kits gained traction in clinical diagnosis of various disease indications in both in vitro and in vivo conditions. These are used for investigational studies of cell activation, assessing cytotoxicity & clinically, in order to determine the therapeutic efficacy. As per the scope of the report, various types of cell proliferation kits were discussed in detail.
| Assay Type | DNA Synthesis Cell Proliferation Assay | |
| Metabolic Activity Cell Proliferation Assay | ||
| Antigen Associated Cell Proliferation Assay | ||
| Method | Colorimetry | |
| Fluorescence | ||
| Others | ||
| End-user | Pharma & Biotech Companies | |
| Academic & Research Institutes | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Cell Proliferation Kit Market Research FAQs
What is the current Cell Proliferation Kit Market size?
The Cell Proliferation Kit Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Cell Proliferation Kit Market?
Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company and Agilent Technologies Inc (BioTek Instruments Inc) are the major companies operating in the Cell Proliferation Kit Market.
Which is the fastest growing region in Cell Proliferation Kit Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Cell Proliferation Kit Market?
In 2024, the North America accounts for the largest market share in Cell Proliferation Kit Market.
What years does this Cell Proliferation Kit Market cover?
The report covers the Cell Proliferation Kit Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cell Proliferation Kit Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Cell Proliferation Kit Industry Report
Statistics for the 2024 Cell Proliferation Kit market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Cell Proliferation Kit analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
